YvetteMBordelonMDPhD
Neurology • Los Angeles, CAAssistant Professor, Neurology, UCLA School of Medicine
Dr. Bordelon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Cedars-Sinai Medical Center
127 S San Vicente Blvd
Los Angeles, CA 90048Phone+1 310-423-6472Fax+1 310-206-2154
Summary
- Dr. Yvette Bordelon is a neurologist in Los Angeles, CA and is affiliated with Cedars Sinai Medical Center. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 20 years. She is experienced in movement disorders, Parkinson’s disease, Huntington’s disease and DBS. She has more than 90 publications and over 500 citings.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2000 - 2003
University of Pennsylvania Health SystemInternship, Internal Medicine, 1999 - 2000
Perelman School of Medicine at the University of PennsylvaniaClass of 1999
Certifications & Licensure
CA State Medical License 2004 - 2026
MA State Medical License 2001 - 2006
NY State Medical License 2003 - 2005
PA State Medical License 1999 - 2000- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
- A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy Start of enrollment: 2015 Apr 01
- Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy Start of enrollment: 2015 Oct 02
- Join now to see all
Publications & Presentations
PubMed
- 182 citationsEvidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseasesGiovanni Coppola, Subashchandrabose Chinnathambi, Jason Lee, Beth A. Dombroski, Matt Baker
Human Molecular Genetics. 2012-08-01 - 425 citationsIdentification of common variants influencing risk of the tauopathy progressive supranuclear palsyGünter U. Höglinger, Nadine M. Melhem, Dennis W. Dickson, Patrick M. A. Sleiman, Li-San Wang
Nature Genetics. 2011-07-01 - 38 citationsClinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical TrialsKevin M. Biglan, Ira Shoulson, Karl Kieburtz, David Oakes, Elise Kayson
JAMA Neurology. 2016-01-01
Press Mentions
Cedars-Sinai Selected as Specialized Center of Care for Patients with Rare Movement DisordersOctober 2nd, 2024
Grant Support
- Identification Of Biomarkers Of Huntington Disease In Human And RATNational Institute Of Neurological Disorders And Stroke2008–2012
- DNA Cleavage In Excitotoxic Cell Death In StriatumNational Institute Of Mental Health1994–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
